UNICA IRIS Institutional Research Information System

SCHERMA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 118.745
NA - Nord America 6.618
AS - Asia 3.218
SA - Sud America 483
AF - Africa 100
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 129.177
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 116.999
US - Stati Uniti d'America 6.492
SG - Singapore 1.205
CN - Cina 1.051
SE - Svezia 440
BR - Brasile 385
VN - Vietnam 315
UA - Ucraina 288
DE - Germania 225
FI - Finlandia 206
GB - Regno Unito 192
FR - Francia 136
IN - India 99
HK - Hong Kong 87
KR - Corea 77
CA - Canada 68
TR - Turchia 65
NL - Olanda 62
BD - Bangladesh 49
AR - Argentina 40
IQ - Iraq 39
ES - Italia 38
JP - Giappone 30
MX - Messico 30
PL - Polonia 29
PK - Pakistan 28
AT - Austria 22
SA - Arabia Saudita 22
ZA - Sudafrica 22
MA - Marocco 20
UZ - Uzbekistan 20
EC - Ecuador 19
PH - Filippine 15
BE - Belgio 14
RU - Federazione Russa 14
IE - Irlanda 13
JO - Giordania 13
CZ - Repubblica Ceca 12
IR - Iran 12
CO - Colombia 11
NP - Nepal 11
ET - Etiopia 10
EG - Egitto 9
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
VE - Venezuela 8
AU - Australia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
CL - Cile 6
MY - Malesia 6
DO - Repubblica Dominicana 5
GR - Grecia 5
HR - Croazia 5
JM - Giamaica 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
CI - Costa d'Avorio 4
DZ - Algeria 4
GE - Georgia 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
PY - Paraguay 3
RO - Romania 3
EU - Europa 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
NA - Namibia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
SR - Suriname 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
Totale 129.154
Salva come PNG Salva come JPEG
Città #
Cagliari 113.298
Uta 3.221
Ashburn 671
Singapore 597
Fairfield 589
Woodbridge 416
Dallas 398
San Jose 391
Chandler 360
Houston 299
Ann Arbor 279
Boardman 257
Nyköping 255
Seattle 248
Wilmington 208
Beijing 193
Cambridge 186
Jacksonville 150
Los Angeles 146
Dearborn 127
Helsinki 119
Council Bluffs 116
New York 113
Shanghai 112
Santa Clara 100
Hefei 87
Ho Chi Minh City 83
Hong Kong 78
The Dalles 74
Boston 73
Lauterbourg 71
Seoul 68
Hanoi 67
Munich 62
Nanjing 61
Dong Ket 45
Frankfurt am Main 39
Milan 36
Chennai 35
Buffalo 34
Orem 34
San Diego 34
Shenyang 34
São Paulo 33
Rome 32
Washington 31
Redwood City 29
Turku 29
Denver 28
London 26
Amsterdam 24
Kocaeli 24
Tokyo 24
Madrid 22
Atlanta 21
Chicago 21
Guangzhou 21
Redondo Beach 21
Warsaw 21
Mountain View 19
Toronto 19
Manchester 18
Montreal 18
Tashkent 18
Tianjin 17
Nuremberg 16
Phoenix 16
Poplar 16
Baghdad 15
Brooklyn 15
Sassari 15
Verona 15
Wuhan 15
Baltimore 13
Brussels 13
Dublin 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Stockholm 13
Da Nang 12
Lappeenranta 12
Rio de Janeiro 12
Vienna 12
Amman 11
Brasília 11
Casablanca 11
Changsha 11
Johannesburg 11
Mexico City 11
Addis Ababa 10
Arlington 10
City of London 10
Porto Alegre 10
San Francisco 10
Shenzhen 10
Tertenìa 10
Mumbai 9
Ningbo 9
Norwalk 9
Totale 124.805
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.670
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.898
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.372
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.354
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.340
Emotional profile of female rats showing binge eating behavior 3.256
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.090
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.965
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.959
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.895
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.874
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.833
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.819
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.718
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.598
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.592
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.509
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.478
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.395
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.384
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.349
Brain activity of anandamide: a rewarding bliss? 2.277
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.227
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.225
Animal Models of Eating Disorders 2.165
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.015
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.954
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.876
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.865
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.793
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.762
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.672
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.642
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.499
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.486
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.444
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.429
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.360
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.336
Cannabinoids and their therapeutic applications in mental disorders 1.269
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.247
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.155
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.135
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.071
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.057
Cannabinoid-opioid interaction in relapse to drug-seeking 1.054
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.041
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.027
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.017
Endocannabinoid system and opioid addiction: behavioural aspects 1.012
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 992
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 963
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 955
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 942
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 863
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 860
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 834
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 800
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 773
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 768
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 758
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 748
null 738
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 733
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 711
null 711
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 671
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 576
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 563
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 561
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 542
An overall view of the most common experimental models for multiple sclerosis 524
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 517
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 469
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 435
Modeling Anorexia Nervosa 389
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 360
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 337
Cannabinoids and reward: Interactions with the opioid system 328
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 290
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 268
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 254
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 184
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 165
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 162
Antibody conjugates in neuroblastoma: a step forward in precision medicine 135
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 114
Cannabinoid-nicotine interactions 48
Totale 129.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.310 0 0 0 0 0 0 0 0 0 0 1.330 980
2021/20227.549 998 507 284 662 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20266.430 749 510 777 635 551 531 979 306 482 899 11 0
Totale 129.501